Giant compound odontoma of the mandible in an adolescent

Abstract Odontomas are one type of benign odontogenic hamartoma that includes the compound and complex odontoma. They are generally reported not to exceed 3 cm in diameter. Odontomas with a diameter exceeding 3 cm are considered giant odontomas. An accurate diagnosis of odontomas cannot be made during the clinical examination. The majority of compound odontoma is diagnosed most commonly during radiographic screening. It should be done in coordination with a histological examination after surgical treatment. We report a case of giant compound odontoma of the mandible in a young boy. The tumor is treated by surgical excision under general anesthesia

EFFECT OF CULTURE CONDITIONS FOR ANTIMICROBIAL ACTIVITY OF MARINE - DERIVED FUNGUS ASPERGILLUS FLOCCULOSUS 01NT.1.1.5

The biosynthesis of compounds with antibiotic activity produced by marine fungi, strongly depends on their growth conditions. A good understanding of the role of culture conditions in the biosynthesis of metabolites may lead to better exploitation of microbial metabolites. In this study, the influence of culture conditions including incubation period, initial pH and salinity on antimicrobial activity and secondary metabolites production of marine fungus 01NT.1.1.5 was investigated. This isolate, obtained from sponge Stylissa sp. in Nha Trang Bay, exhibited a broad spectrum of in vitro antimicrobial activity to Bacillus cereus ATCC 11778, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Listeria monocytogenes ATCC 19111, Streptococcus faecalis ATCC 19433 and Candida albicans ATCC 10231. According to morphological characteristics and sequence analysis of 28S rDNA, the fungus was identified as Aspergillus flocculosus. The results indicated that antimicrobial activity and metabolite amount were highest when the fungus was cultivated in rice medium with incubation period of 20 days. The optimum salinity of 35 g/L and initial pH of 6.0 were found for the maximum antibiotic production. The colony growth, antimicrobial activity and production of secondary metabolites of the strain A. flocculosus 01NT.1.1.5 varied depending on salt concentrations and initial pH of medium. Particularly, extract of this fungus only showed activity against C. albicans when it was cultured in medium with 30-35 g/L salinity and initial pH 4.0-8.0. The results  indicate that salinity and initial pH along with cultivation period are important factors influencing antimicrobial activity and secondary metabolites of A. flocculosus 01NT.1.1.5, and might be for other marine fungi

Associations of Underlying Health Conditions With Anxiety and Depression Among Outpatients: Modification Effects of Suspected COVID-19 Symptoms, Health-Related and Preventive Behaviors

Objectives: We explored the association of underlying health conditions (UHC) with depression and anxiety, and examined the modification effects of suspected COVID-19 symptoms (S-COVID-19-S), health-related behaviors (HB), and preventive behaviors (PB).Methods: A cross-sectional study was conducted on 8,291 outpatients aged 18–85 years, in 18 hospitals and health centers across Vietnam from 14th February to May 31, 2020. We collected the data regarding participant's characteristics, UHC, HB, PB, depression, and anxiety.Results: People with UHC had higher odds of depression (OR = 2.11; p < 0.001) and anxiety (OR = 2.86; p < 0.001) than those without UHC. The odds of depression and anxiety were significantly higher for those with UHC and S-COVID-19-S (p < 0.001); and were significantly lower for those had UHC and interacted with “unchanged/more” physical activity (p < 0.001), or “unchanged/more” drinking (p < 0.001 for only anxiety), or “unchanged/healthier” eating (p < 0.001), and high PB score (p < 0.001), as compared to those without UHC and without S-COVID-19-S, “never/stopped/less” physical activity, drinking, “less healthy” eating, and low PB score, respectively.Conclusion: S-COVID-19-S worsen psychological health in patients with UHC. Physical activity, drinking, healthier eating, and high PB score were protective factors

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

The efficacy of silver‐based electrospun antimicrobial dressing in accelerating the regeneration of partial thickness burn wounds using a porcine model

(1) Background: Wounds with damages to the subcutaneous are difficult to regenerate because of the tissue damages and complications such as bacterial infection. (2) Methods: In this study, we created burn wounds on pigs and investigated the efficacy of three biomaterials: polycaprolactone‐gelatin‐silver membrane (PCLGelAg) and two commercial burn dressings, Aquacel® Ag and UrgoTul™ silver sulfadiazine. In vitro long‐term antibacterial property and in vivo wound healing performance were investigated. Agar diffusion assays were employed to evaluate bacterial inhibition at different time intervals. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time‐kill assays were used to compare antibacterial strength among samples. Second‐degree burn wounds in the pig model were designed to evaluate the efficiency of all dressings in supporting the wound healing process. (3) Results: The results showed that PCLGelAg membrane was the most effective in killing both Gram‐positive and Gram-negative bacteria bacteria with the lowest MBC value. All three dressings (PCLGelAg, Aquacel, and UrgoTul) exhibited bactericidal effect during the first 24 h, supported wound healing as well as prevented infection and inflammation. (4) Conclusions: The results suggest that the PCLGelAg membrane is a practical solution for the treatment of severe burn injury and other infection‐related skin complications.</p

Optimization design for die-sinking EDM process parameters employing effective intelligent method

AbstractElectrical discharge machining (EDM) is a highly regarded method for producing ultra-precise mechanical parts. In this study, the process parameters of die-sinking EDM using copper electrodes and American Iron and Steel Institute (AISI) P20 tool steel workpieces are optimized for various output responses. The study surveys three input parameters, including Current (I), Pulse on Time (Ton), and Pulse Off Time (Toff). Some statistical methods, such as Taguchi and Analysis of Variance (ANOVA), are applied to find the optimal set of parameters for the output responses, consisting of Material Removal Rate (MRR), Electrode Wear Rate (EWR), and Surface Roughness (SR), and determine the most influential input factor. With the L9 Orthogonal Array (OA), the analytical results demonstrate the optimal parameter set for MRR is I = 6 A, Ton = 120 µs, and Toff = 30 µs, while those optimal values for EWR and SR are I = 2 A, Ton = 120 µs, and Toff = 90 µs and I = 2 A, Ton = 60 µs, and Toff = 30 µs, respectively. The study also indicates that input factor I has the most effect on the output responses, followed by Ton and Toff. Moreover, Grey relational analysis in the Taguchi method is also employed for multi-response optimization. The optimal parameter set for the three output factors is I = 6 A, Ton = 120 µs, and Toff = 60 µs, respectively. In this research, the microstructure and recast layer of the machined surfaces are investigated using optical microscopy as well

A novel multi‐stage enrichment workflow and comprehensive characterization for HEK293F‐derived extracellular vesicles

Abstract Extracellular vesicles (EVs) are emerging as a promising drug delivery vehicle as they are biocompatible and capable of targeted delivery. However, clinical translation of EVs remains challenging due to the lack of standardized and scalable manufacturing protocols to consistently isolate small EVs (sEVs) with both high yield and high purity. The heterogenous nature of sEVs leading to unknown composition of biocargos causes further pushback due to safety concerns. In order to address these issues, we developed a robust quality‐controlled multi‐stage process to produce and isolate sEVs from human embryonic kidney HEK293F cells. We then compared different 2‐step and 3‐step workflows for eliminating protein impurities and cell‐free nucleic acids to meet acceptable limits of regulatory authorities. Our results showed that sEV production was maximized when HEK293F cells were grown at high‐density stationary phase in semi‐continuous culture. The novel 3‐step workflow combining tangential flow filtration, sucrose‐cushion ultracentrifugation and bind‐elute size‐exclusion chromatography outperformed other methods in sEV purity while still preserved high yield and particle integrity. The purified HEK293F‐derived sEVs were thoroughly characterized for identity including sub‐population analysis, content profiling including proteomics and miRNA sequencing, and demonstrated excellent preclinical safety profile in both in‐vitro and in‐vivo testing. Our rigorous enrichment workflow and comprehensive characterization will help advance the development of EVs, particularly HEK293F‐derived sEVs, to be safe and reliable drug carriers for therapeutic applications